Design of Small Molecule Allosteric Inhibitors of KRAS

Time: 3:00 pm
day: Day One


• We will present the in vitro and in vivo results of a series of orally available small molecules that were designed following an in silico approach

• These novel therapeutics bind onto an allosteric site of KRAS